Civic IQ
Reportongoing

nj-department-of-human-services-drug-utilization-review-board-agenda-october-2025_148.pdf

Gainwell Technologies Reports on Drug Utilization in NJ

NANJ Department of Human ServicesGAINWELLOctober 22, 2025

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

Gainwell Technologies presents the NJ MCO 2nd Quarter 2025 Prior Authorization Report, offering insights into drug utilization and approval trends within New Jersey's managed care organizations. The report provides a detailed analysis of prior authorization requests, denial rates, and the reasons behind denials across various therapeutic drug classifications.

Contract Details

Contract Amount

NA

Vendor

GAINWELL

Agency

NJ Department of Human Services, NJ

Contract Type

Report

Document Date

October 22, 2025

Contract Term

NA

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free